Charles Schwab Investment Management Inc Sorrento Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.74 - $1.83 $499,289 - $1.23 Million	674,716 Added 23.81%	3,508,377 $3.12 Million
Q3 2022 Nov 14, 2022	BUY	$1.51 - $2.88 $100,803 - $192,260	66,757 Added 2.41%	2,833,661 $4.45 Million
Q2 2022 Aug 15, 2022	BUY	$1.24 - $2.33 $700,869 - $1.32 Million	565,217 Added 25.67%	2,766,904 $5.56 Million
Q1 2022 May 13, 2022	BUY	$2.0 - $4.9 $117,186 - $287,105	58,593 Added 2.73%	2,201,687 $5.13 Million
Q4 2021 Feb 11, 2022	BUY	$4.65 - $7.23 $513,099 - $797,787	110,344 Added 5.43%	2,143,094 $9.97 Million
Q3 2021 Nov 16, 2021	BUY	$7.41 - $10.99 $2.24 Million - $3.32 Million	302,190 Added 17.46%	2,032,750 $15.5 Million
Q2 2021 Aug 16, 2021	BUY	$6.35 - $10.0 $579,793 - $913,060	91,306 Added 5.57%	1,730,560 $16.8 Million
Q1 2021 May 17, 2021	BUY	$7.03 - $16.51 $820,436 - $1.93 Million	116,705 Added 7.67%	1,639,254 $13.6 Million
Q4 2020 Feb 16, 2021	BUY	$5.76 - $11.95 $878,284 - $1.82 Million	152,480 Added 11.13%	1,522,549 $10.4 Million
Q3 2020 Nov 13, 2020	BUY	$6.17 - $18.82 $5.72 Million - $17.5 Million	927,446 Added 209.53%	1,370,069 $15.3 Million
Q2 2020 Aug 14, 2020	BUY	$1.73 - $6.76 $202,636 - $791,805	117,131 Added 35.99%	442,623 $2.78 Million
Q1 2020 May 15, 2020	BUY	$1.57 - $4.76 $13,286 - $40,283	8,463 Added 2.67%	325,492 $599,000
Q4 2019 Feb 07, 2020	BUY	$1.45 - $4.17 $34,646 - $99,637	23,894 Added 8.15%	317,029 $1.07 Million
Q3 2019 Nov 08, 2019	BUY	$2.05 - $2.69 $38,312 - $50,273	18,689 Added 6.81%	293,135 $628,000
Q2 2019 Aug 09, 2019	BUY	$2.67 - $4.38 $107,312 - $176,040	40,192 Added 17.16%	274,446 $733,000
Q1 2019 May 14, 2019	SELL	$1.86 - $5.94 $71,444 - $228,161	-38,411 Reduced 14.09%	234,254 $1.11 Million
Q4 2018 Feb 14, 2019	BUY	$2.01 - $4.24 $71,535 - $150,901	35,590 Added 15.01%	272,665 $655,000
Q3 2018 Nov 13, 2018	BUY	$4.22 - $7.5 $241,113 - $428,520	57,136 Added 31.75%	237,075 $1.04 Million
Q2 2018 Aug 08, 2018	BUY	$4.75 - $8.0 $769,500 - $1.3 Million	162,000 Added 903.06%	179,939 $1.3 Million
Q1 2018 May 07, 2018	BUY	$4.5 - $9.95 $80,725 - $178,493	17,939 New	17,939 $93,000

Others Institutions Holding SRNE

# of Institutions

Shares Held

5.47M

Call Options Held

Put Options Held

View Full List

About Sorrento Therapeutics, Inc.

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

More about SRNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account